Ibrutinib for CLL within a population-based setting: a promising outlook
Lina van der Straten • 14 Jun 2018
How to manage infections after hematopoietic stem cell transplantation and the issue of resistance
Jan Styczynski • 9 Sep 2016
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
John Gribben • 17 Sep 2016